1. Optovue

    0 Comments Leave a Comment

    1-15 of 571 1 2 3 4 ... 36 37 38 »
    1. Mentioned In 571 Articles

    2. Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health

      Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health
      ..., 2017, and the American Academy of Ophthalmology meeting in New Orleans, November 11-14, 2017. About Optovue Optovue, Inc. is a privately held medical device company founded in 2003. Headquartered in Fremont, Calif., th...
      Read Full Article
      Mentions: Optovue Jay Wei FDA
    3. Longitudinal Changes in Retinal Nerve Fiber Layer Thickness Evaluated Using Avanti Rtvue-XR Optical Coherence Tomography after 23G Vitrectomy for Epiretinal Membrane in Patients with Open-Angle Glaucoma

      Longitudinal Changes in Retinal Nerve Fiber Layer Thickness Evaluated Using Avanti Rtvue-XR Optical Coherence Tomography after 23G Vitrectomy for Epiretinal Membrane in Patients with Open-Angle Glaucoma
      Objectives . The aim of this study is to evaluate longitudinal RNFL thickness changes in patients with open-angle glaucoma (OAG) who underwent pars plana vitrectomy (PPV) with epiretinal membrane (ERM) and ILM removal using OCT RTVue XR 100 Avanti. Methods . Retrospective analysis of OCT scans of 40 patients who underwent PPV or combined phacovitrectomy with ILM peeling for the idiopathic ERM has been carried out. The patients were divided into two ...
      Read Full Article
      Mentions: Optovue
    4. Evaluation of macular and peripapillary vessel flow density in eyes with no known pathology using optical coherence tomography angiography

      Evaluation of macular and peripapillary vessel flow density in eyes with no known pathology using optical coherence tomography angiography
      ... eyes with no known ocular pathology using optical coherence tomography angiography (OCTA). Methods AngioVue (Optovue, Fremont, CA, USA) was used to capture OCTA images. A 3 3 mm grid and a 4.5 4.5 mm grid was used to ...
      Read Full Article
    5. Retinal Vascular Autoregulation during Phase IV of the Valsalva Maneuver: An Optical Coherence Tomography Angiography Study in Healthy Chinese Adults

      Retinal Vascular Autoregulation during Phase IV of the Valsalva Maneuver: An Optical Coherence Tomography Angiography Study in Healthy Chinese Adults
      ...mally for 20 min. The baseline OCTA scans were then performed with a spectral domain system (RTVue-XR Avanti; Optovue, Fremont, CA, USA; software version 2015.1.0.90) (Jia et al., 2012b; Yu et al., 2015), by a single obs...
      Read Full Article
    6. 1-15 of 571 1 2 3 4 ... 36 37 38 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Optovue

    Optovue

    Optovue, Inc., a privately-held medical device company founded in 2003 and based in Fremont, Calif., is dedicated to the development and commercialization of high-speed optical coherence technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. For more information, visit www.optovue.com.

  3. Quotes about Optovue

    1. Our customers around the world provided a 19% revenue increase for 2009 over 2008...We have continuing strong support by representatives and distributor's world-wide, and all regions including the US are up significantly from 2008. The first fiscal quarter of 2010 demonstrated still another significant increase over 2009 numbers. The trend is clearly demonstrating that the clinical package offered by Optovue products is still highly desirable when faced with a number of product options.
      Gordon Wong in Optovue Announces 19% 2009 Revenue Increase Over 2008
    2. Gaining market share in the home country where Optovue manufactures is always satisfying...“Gaining market share in the home country where Optovue manufactures is always satisfying...The mission in 2012 is to continue our market growth world-wide utilizing our new TCP (Total Cornea Power) and V TRAC (Eye Tracking) options; as well as expand our iWellness programs.
      In Optovue Announces US sales orders for advanced OCT up 32% over previous year
    3. Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry.
      In Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle